Robert J Kiernan

Insider

First SEC filing: June 2, 2017 · Latest: June 2, 2017

On this page

Insider at Companies where this person is a reporting insider.
Insider transactions Every share this person bought or sold, from Form 4 filings.
Derivatives Options and other derivative holdings reported by this person.
Compensation Executive pay disclosed in company proxy statements.

Insider at

XRN buying May 11, 2026

Insider transactions

2 buys (P) 0 sells (S) Net: $196,200 + 52 non-open-market transactions below Avg return of open purchases vs now: 12.6% last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

52 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D	vs now
May 11, 2026	XRN	P	3,000	$33.49	$100,470	6,000 Direct	+100.00%	Acquired	9.8% (price as of 2026-08-20)
Feb. 24, 2026	XRN	A	3,492	—	—	99,552 Direct	+3.64%	Acquired	(price as of 2026-08-20)
Feb. 24, 2026	XRN	A	10,385	—	—	96,060 Direct	+12.12%	Acquired	(price as of 2026-08-20)
Nov. 14, 2025	XRN	P	3,000	$31.91	$95,730	3,000 Direct	—	Acquired	15.3% (price as of 2026-08-20)
Feb. 26, 2025	XRN	A	13,493	—	—	428,374 Direct	+3.25%	Acquired	(price as of 2026-08-20)
Feb. 26, 2025	XRN	A	46,069	—	—	414,881 Direct	+12.49%	Acquired	(price as of 2026-08-20)
Feb. 21, 2024	XRN	A	18,549	—	—	368,812 Direct	+5.30%	Acquired	(price as of 2026-08-20)
Feb. 21, 2024	XRN	A	38,860	—	—	350,263 Direct	+12.48%	Acquired	(price as of 2026-08-20)
Feb. 28, 2023	XRN	A	7,601	—	—	311,403 Direct	+2.50%	Acquired	(price as of 2026-08-20)
Feb. 23, 2023	XRN	A	27,422	—	—	303,802 Direct	+9.92%	Acquired	(price as of 2026-08-20)
Feb. 28, 2022	XRN	A	10,114	—	—	257,112 Direct	+4.09%	Acquired	(price as of 2026-08-20)
Feb. 24, 2022	XRN	A	9,905	—	—	246,998 Direct	+4.18%	Acquired	(price as of 2026-08-20)
May 26, 2021	XRN	A	5,927	—	—	237,093 Direct	+2.56%	Acquired	(price as of 2026-08-20)
March 2, 2021	XRN	A	28,660	—	—	231,166 Direct	+14.15%	Acquired	(price as of 2026-08-20)
March 2, 2021	XRN	A	27,434	—	—	202,506 Direct	+15.67%	Acquired	(price as of 2026-08-20)
Aug. 28, 2020	XRN	A	21,242	—	—	175,072 Direct	+13.81%	Acquired	(price as of 2026-08-20)
July 9, 2020	XRN	A	71,702	—	—	153,830 Direct	+87.31%	Acquired	(price as of 2026-08-20)
March 3, 2020	XRN	A	5,020	—	—	82,128 Direct	+6.51%	Acquired	(price as of 2026-08-20)
March 3, 2020	XRN	A	16,832	—	—	77,108 Direct	+27.92%	Acquired	(price as of 2026-08-20)
March 5, 2019	XRN	A	3,250	—	—	60,276 Direct	+5.70%	Acquired	(price as of 2026-08-20)
March 5, 2019	XRN	A	6,356	—	—	57,026 Direct	+12.54%	Acquired	(price as of 2026-08-20)
March 5, 2019	XRN	A	13,275	—	—	50,670 Direct	+35.50%	Acquired	(price as of 2026-08-20)
March 5, 2018	XRN	A	9,469	—	—	37,395 Direct	+33.91%	Acquired	(price as of 2026-08-20)
March 5, 2018	XRN	A	19,727	—	—	27,926 Direct	+240.60%	Acquired	(price as of 2026-08-20)
March 5, 2018	XRN	A	2,225	—	—	8,199 Direct	+37.24%	Acquired	(price as of 2026-08-20)
June 1, 2017	1371446	D	8,429	—	—	0 Direct	-100.00%	Disposed
March 8, 2017	1371446	A	860	—	—	8,429 Direct	+11.36%	Acquired
Feb. 8, 2016	1371446	F	1,013	$16.28	$16,492	7,569 Direct	-11.80%	Disposed
March 9, 2015	1371446	F	386	$24.12	$9,310	8,491 Direct	-4.35%	Disposed
March 10, 2014	1371446	F	387	$26.69	$10,329	8,720 Direct	-4.25%	Disposed
Sept. 18, 2013	1371446	F	443	$27.25	$12,072	9,078 Direct	-4.65%	Disposed
March 8, 2013	1371446	F	355	$17.53	$6,223	11,205 Direct	-3.07%	Disposed
Sept. 18, 2012	1371446	F	1,771	$3.29	$5,827	46,240 Direct	-3.69%	Disposed
June 8, 2012	1371446	F	1,172	$2.82	$3,305	48,011 Direct	-2.38%	Disposed
Feb. 8, 2012	1371446	A	6,974	$2.39	$16,668	48,984 Direct	+16.60%	Acquired
Sept. 18, 2011	1371446	F	1,758	$2.69	$4,729	42,010 Direct	-4.02%	Disposed
June 8, 2011	1371446	F	1,172	$3.41	$3,997	43,768 Direct	-2.61%	Disposed
Jan. 31, 2011	1371446	A	554	—	—	44,940 Direct	+1.25%	Acquired
June 8, 2010	1371446	F	1,090	$3.72	$4,055	44,386 Direct	-2.40%	Disposed
March 8, 2010	1371446	A	6,000	—	—	6,000 Direct	—	Acquired
March 8, 2010	1371446	A	8,000	—	—	45,476 Direct	+21.35%	Acquired
March 8, 2010	1371446	A	12,000	—	—	37,476 Direct	+47.10%	Acquired
Jan. 29, 2010	1371446	A	476	$6.13	$2,918	25,476 Direct	+1.90%	Acquired
Sept. 18, 2008	1371446	A	15,000	$4.76	$71,400	25,000 Direct	+150.00%	Acquired
June 8, 2007	1371446	A	10,000	—	—	10,000 Direct	—	Acquired
Jan. 12, 2007	1209028	J	4,319	$8.25	$35,632	10,009 Direct	+75.91%	Acquired
June 30, 2006	1209028	J	750	$8.41	$6,308	4,810 Direct	+18.47%	Acquired
Dec. 30, 2005	1209028	J	610	$8.60	$5,246	3,969 Direct	+18.16%	Acquired
June 30, 2005	1209028	J	553	$12.03	$6,653	3,061 Direct	+22.05%	Acquired
Dec. 31, 2004	1209028	J	315	$16.69	$5,257	2,508 Direct	+14.36%	Acquired
June 30, 2004	1209028	A	2,000	—	—	7,000 Direct	+40.00%	Acquired
June 30, 2004	1209028	J	285	$18.41	$5,247	2,193 Direct	+14.94%	Acquired
March 1, 2004	1209028	A	1,000	—	—	1,908 Direct	+110.13%	Acquired
Dec. 31, 2003	1209028	J	353	$12.73	$4,494	908 Direct	+63.60%	Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
Feb. 24, 2026	XRN	LTIP Unit (Right to Buy) [F3]	Common Stock (3,492)	—	—	3,492	Acquired
Feb. 24, 2026	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (10,385)	—	—	10,385	Acquired
Feb. 26, 2025	XRN	LTIP Unit (Right to Buy) [F3]	Common Stock (13,493)	—	—	13,493	Acquired
Feb. 26, 2025	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (46,069)	—	—	46,069	Acquired
Feb. 21, 2024	XRN	LTIP Unit (Right to Buy) [F3]	Common Stock (18,549)	—	—	18,549	Acquired
Feb. 21, 2024	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (38,860)	—	—	38,860	Acquired
Feb. 28, 2023	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (7,601)	—	—	7,601	Acquired
Feb. 23, 2023	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (27,422)	—	—	27,422	Acquired
Feb. 28, 2022	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (10,114)	—	—	10,114	Acquired
Feb. 24, 2022	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (9,905)	—	—	9,905	Acquired
May 26, 2021	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (5,927)	—	—	5,927	Acquired
March 2, 2021	XRN	LTIP Unit (Right to Buy) [F3]	Common Stock (28,660)	—	—	28,660	Acquired
March 2, 2021	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (27,434)	—	—	27,434	Acquired
Aug. 28, 2020	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (21,242)	—	—	21,242	Acquired
July 9, 2020	XRN	LTIP Unit [F1]	Common Stock (71,702)	—	—	71,702	Acquired
March 3, 2020	XRN	LTIP Unit (Right to Buy) [F3]	Common Stock (5,020)	—	—	5,020	Acquired
March 3, 2020	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (16,832)	—	—	16,832	Acquired
March 5, 2019	XRN	LTIP Unit (Right to Buy) [F5]	Common Stock (3,250)	—	—	3,250	Acquired
March 5, 2019	XRN	LTIP Unit (Right to Buy) [F4]	Common Stock (6,356)	—	—	6,356	Acquired
March 5, 2019	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (13,275)	—	—	13,275	Acquired
March 5, 2018	XRN	LTIP Unit (Right to Buy) [F5]	Common Stock (9,469)	—	—	9,469	Acquired
March 5, 2018	XRN	LTIP Unit (Right to Buy) [F4]	Common Stock (19,727)	—	—	19,727	Acquired
March 5, 2018	XRN	LTIP Unit (Right to Buy) [F1]	Common Stock (2,225)	—	—	2,225	Acquired
March 8, 2010	1371446	Right to buy common stock	Common Stock (6,000)	$5.63	March 8, 2017	6,000	Acquired
June 30, 2004	1209028	Class A Common Stock (Right to Buy)	Common Stock (2,000)	$19.38	June 30, 2009	2,000	Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

XRN

Fiscal year	Salary	Bonus	Stock awards	Option awards	Non-equity incentive	Pension change	Other	Total
2023	$400,000	—	$760,000	—	$253,200	—	—	$1,413,200
2021	$335,000	—	$334,000	—	$204,794	—	—	$873,794
2018	—	—	$415,983	—	—	—	—	$440,504

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.